First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
Aiping Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinan Sheng(Peking University), Yi He(University of Michigan), Xudong Yao(Shanghai Tenth People's Hospital), S. Wang(Tongji Hospital), Jianghou Wan(First Hospital of Lanzhou University), Jitao Wu(Qingdao University), Anqi Yang(Xiamen University), Pengfei Shen(Sichuan University), Mulati Rexiati(Xinjiang Medical University), Zhisong He(Peking University), Xin Gou(Guangxi University), Yu Zeng(University of Science and Technology of China), Yongquan Wang, Zhigang Ji(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinhua Tu(Jiangxi Provincial Cancer Hospital), Jun Guo(Peking University), Yuan Li(Liaocheng University), Weijun Qin(Xijing Hospital), Juan Li(Sun Yat-sen University), Lian Liu(Qilu Hospital of Shandong University), Gang Li(Qiqihar Medical University), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), De‐Xin Yu(Anhui Medical University), Peng Chen(Wannan Medical College), Xu Zhang(Chinese PLA General Hospital), Tie Chong(Second Affiliated Hospital of Xi'an Jiaotong University), Fei Jing(Baoji University of Arts and Sciences), Zengjun Wang(Jiangsu Province Hospital), Ziling Liu(Jilin University), Jin Wu(Harbin Medical University), Bin Fu(Nanchang University), Benkang Shi(Qilu Hospital of Shandong University), Tongjian Cui(Fujian Medical University), Kui Jiang(Dalian Medical University), Liqun Jia(Beijing Children’s Hospital), Shusuan Jiang(Hunan Cancer Hospital), Fangjian Zhou(Sun Yat-sen University), Hongqian Guo(Nanjing Drum Tower Hospital), Wang Qu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lulin Ma(Peking University)
Cited by 10
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
The duck genome and transcriptome provide insight into an avian influenza virus reservoir species
|Nature Genetics|2013|460
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
|Nature Communications|2023|230